For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Montelukast Sodium | Accord Healthcare Inc. and its risk associated with lactation. We will also discuss the usage of Montelukast Sodium | Accord Healthcare Inc. and some common side effects associated with Montelukast Sodium | Accord Healthcare Inc..
What is Montelukast Sodium | Accord Healthcare Inc. used for?
Montelukast sodium tablets are a leukotriene receptor antagonist indicated for: Prophylaxis and chronic treatment of asthma in patients 15 years of age and older ( 1.1). Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older ( 1.2). Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 15 years of age and older, and perennial allergic rhinitis (PAR) in patients 15 years of age and older ( 1.3). 1.1 Asthma Montelukast sodium tablet is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 15 years of age and older. 1.2 Exercise-Induced Bronchoconstriction (EIB) Montelukast sodium tablet is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older. 1.3 Allergic Rhinitis Montelukast sodium tablet is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 15 years of age and older and perennial allergic rhinitis in patients 15 years of age and older.
I am currently breastfeeding and I want to know if using Montelukast Sodium | Accord Healthcare Inc. is safe for my kid? Does it have any effect on milk production?
Montelukast is the only one ingredient used in manufacturing of Montelukast Sodium | Accord Healthcare Inc., Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Montelukast it is safe to use Montelukast Sodium | Accord Healthcare Inc. while lactating. We suggest you to check further details below about Montelukast usage in breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.2 Lactation Risk Summary A published clinical lactation study reports the presence of montelukast in human milk. Data available on the effects of the drug on infants, either directly [see Use in Specific Populations (8.4)] or through breast milk, do not suggest a significant risk of adverse events from exposure to montelukast sodium. The effects of the drug on milk production are unknown. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for montelukast sodium and any potential adverse effects on the breastfed infant from montelukast sodium or from the underlying maternal condition.
Montelukast Sodium | Accord Healthcare Inc. Breastfeeding Analsys
SafeCAS Number: 151767-02-1
Pharmacokinetic data (moderately high molecular weight and high protein-binding capacity) explain an observed very low excretion into breastmilk (Datta 2016). A drug of the same group and similar effect, Zafirlukast, is also excreted into breastmilk in non-significant amounts. It is a licensed medication to be used in infants from 6 months of age on. Indeed, it has been used as early as 3 months of age with the same tolerance observed in older children.
Montelukast Sodium | Accord Healthcare Inc. Breastfeeding Analsys - 2
CAS Number: 158966-92-8
Very low levels of montelukast appear in breastmilk. Montelukast is approved for use in children as young as 6 months of age and has been used in neonates in dosages far greater than the amounts in breastmilk. Amounts ingested by the infant would not be expected to cause any adverse effects in breastfed infants No special precautions are required.
What should I do if I am breastfeeding mother and I am already exposed to Montelukast Sodium | Accord Healthcare Inc.?
It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Montelukast Sodium | Accord Healthcare Inc. and have used it then do not panic as Montelukast Sodium | Accord Healthcare Inc. is mostly safe in breastfeeding and should not cause any harm to your baby.
My health care provider has asked me to use Montelukast Sodium | Accord Healthcare Inc., what to do?
Definitely, Montelukast Sodium | Accord Healthcare Inc. is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Montelukast Sodium | Accord Healthcare Inc., will my baby need extra monitoring?
No extra baby monitoring required while mother is using Montelukast Sodium | Accord Healthcare Inc.
Who can I talk to if I have questions about usage of Montelukast Sodium | Accord Healthcare Inc. in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week
Drug Brands with same Active ingredients